- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Lupin Limited — Updates, 03-10-2025: Press Release
03-10-2025 | 06:13 pm
03-10-2025 | 06:13 pm
Lupin launched Liraglutide Injection, a generic equivalent to Victoza®, in the US market. The reference product had estimated annual sales of USD 350 million, boosting Lupin's complex injectables portfolio.
No comments yet. Be the first to comment!